Nova Leap Health (NLH) AI Stock Analysis

15 Followers

Nova Leap Health

(TSXV:NLH)

Select Model

Rating:67Neutral

Price Target:CAD 0.53▲(8.57% Upside)

Action:reiterated

Date:11/14/26

Strong cash generation and low leverage are the primary supports, with neutral technicals and moderate valuation providing additional stability. Thin profit margins limit further upside.

Positive Factors

Improving ProfitabilityTTM profitability has recovered after the 2025 loss, while EBIT margin also improved. If maintained, this stronger earnings base can support reinvestment and improve operating resilience, although the evidence reflects a recent recovery rather than a long record of consistency.

Negative Factors

Earnings VolatilityThe return to profit is encouraging, but repeated losses and large historical margin swings show that earnings power has not yet demonstrated consistent durability. This volatility makes future profitability less predictable and could limit confidence in sustained returns over the medium term.

Nova Leap Health (NLH) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 42.78M
Dividend Yield: ―
Average Volume (3M): 15.37K
Price to Earnings (P/E): 24.5
Beta (1Y): 0.32
Revenue Growth: 15.57%
EPS Growth: 65.83%
Country: Canada
Employees: 541
Sector: General
Sector Strength: 55
Industry: Medical - Care Facilities

Nova Leap Health Business Overview & Revenue Model

Company Description

Nova Leap Health Corp. delivers a comprehensive array of in-home and healthcare-at-home solutions across the United States and Canada. Their offerings encompass specialized dementia support, social companionship, assistance with personal needs, and t...

Nova Leap Health Financial Statement Overview

Summary

Strong cash flows and stable balance sheet with low debt support the financial position, though thin net margins and earnings volatility constrain the score.

Income Statement

58Neutral

Balance Sheet

76Positive

Cash Flow

81Very Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	34.58M	32.02M	25.76M	26.18M	28.21M	21.28M
Gross Profit	13.31M	11.85M	9.89M	9.77M	9.98M	7.21M
EBITDA	2.65M	1.97M	2.50M	1.35M	420.35K	4.76M
Net Income	1.23M	-193.19K	1.38M	-1.05M	-835.75K	1.76M
Balance Sheet
Total Assets	25.91M	23.44M	22.39M	20.90M	23.95M	26.77M
Cash, Cash Equivalents and Short-Term Investments	1.93M	1.49M	1.40M	894.76K	1.27M	1.73M
Total Debt	4.39M	2.93M	2.53M	1.40M	3.97M	6.20M
Total Liabilities	6.24M	4.43M	4.14M	2.70M	5.27M	8.29M
Stockholders Equity	19.67M	19.01M	18.25M	18.20M	18.68M	18.48M
Cash Flow
Free Cash Flow	2.30M	1.42M	1.36M	2.13M	949.49K	2.18M
Operating Cash Flow	2.27M	1.42M	1.39M	2.15M	1.02M	2.18M
Investing Cash Flow	-2.26M	-1.26M	-1.59M	-23.13K	-56.24K	-7.40M
Financing Cash Flow	369.09K	-86.91K	729.78K	-2.52M	-1.41M	4.33M

Nova Leap Health Technical Analysis

Technical Analysis SentimentPositive

Last Price0.49

Price Trends

50DMA0.50Negative

100DMA0.48Positive

200DMA0.41Positive

Market Momentum

MACD0.00Negative

RSI52.04Neutral

STOCH75.71Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NLH, the sentiment is Positive. The current price of 0.49 is above the 20-day moving average (MA) of 0.47, below the 50-day MA of 0.50, and above the 200-day MA of 0.41, indicating a neutral trend. The MACD of 0.00 indicates Negative momentum. The RSI at 52.04 is Neutral, neither overbought nor oversold. The STOCH value of 75.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NLH.

Nova Leap Health Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TSE:NLH against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:DR	72Outperform	CAD 274.14M	9.27	44.01%	2.12%	4.53%	-55.43%
TSE:SIA	70Outperform	CAD 2.24B	40.03	5.98%	4.63%	14.90%	13.31%
TSE:NLH	67Neutral	CAD 42.78M	24.53	6.40%	―	15.57%	65.83%
TSE:EXE	67Neutral	CAD 2.88B	21.67	32.84%	1.72%	36.24%	29.85%
TSE:CRRX	63Neutral	CAD 203.53M	7.89	23.35%	2.55%	3.42%	40560.00%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

TSE:NLH and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:NLH	Nova Leap Health	0.49	0.19	63.33%
TSE:CRRX	Carerx Corporation	3.22	-0.18	-5.27%
TSE:EXE	Extendicare Inc.	30.34	10.95	56.49%
TSE:SIA	Sienna Senior Living	20.20	0.95	4.92%
TSE:DR	Medical Facilities Corp	16.95	2.96	21.20%

Nova Leap Health Corporate Events

Business Operations and StrategyFinancial Disclosures

Nova Leap to Spotlight Record Quarter and Growth Strategy at Planet MicroCap Showcase

Positive

Oct 14, 2026

Nova Leap Health Corp. will showcase its record second-quarter performance and growth strategy at the Planet MicroCap Showcase in Toronto later this month. President and CEO Chris Dobbin is scheduled to deliver a webcast presentation on October 28, f...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026

Nova Leap Health AI Stock Analysis